Camlin Fine Sciences Limited

NSE: CAMLINFINE · Unclassified

₹76.03-0.13%06 Nov 2026

Ask the data

Instant answers about Camlin Fine Sciences Limited — computed from its filings, no language model

Market cap₹1,460 cr

Current price₹76.03

High / Low₹200 / ₹74

P/E—

P/B1.50

Book value₹50.6

ROE-0.8%

ROCE-1.7%

Debt / equity0.65

Dividend yield—

EPS (TTM)₹-0.40

Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 8 periods

	FY18	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	723	1,049	1,187	1,412	1,682	1,613	1,667	1,723
EBITDA	13	131	182	153	205	74	208	107
Operating margin	1.7%	12.5%	15.3%	10.8%	12.2%	4.6%	12.5%	6.2%
Interest	28	43	38	36	58	60	100	73
Depreciation	27	33	44	56	63	79	64	71
Profit before tax	-31	58	105	94	80	-99	49	-34
Tax	-7	28	40	34	41	6	0	-0
Net profit	-30	30	51	61	52	-93	-139	28
EPS ₹	-0.38	2.50	4.13	4.65	3.45	-5.58	-8.03	1.46
Operating cash flow	—	—	—	145	51	139	27	82
Capex	—	—	—	214	144	61	42	58
Dividend paid	—	—	—	0	0	0	0	0
Total assets	—	—	—	—	2,060	1,952	2,024	2,324
Equity	—	—	—	—	819	865	902	1,041

Quarterly performance

last 33 quarters · ₹ crore

showing latest 8 of 33 periods

	MAR '18	JUN '18	SEP '18	DEC '18	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	232	181	201	241	222	274	293	306	257	298	327	331	311	381	389	384	483	388	427	420	406	386	402	396	423	433	437	424	460	457	425	520	491
Operating profit	10	14	17	15	30	30	34	51	34	47	50	46	23	55	24	47	55	50	44	39	25	23	-13	18	43	49	59	19	33	22	21	9	2
Operating margin	4.5%	7.7%	8.5%	6.4%	13.5%	10.8%	11.7%	16.7%	13.1%	15.7%	15.4%	13.8%	7.3%	14.5%	6.3%	12.1%	11.4%	12.8%	10.3%	9.2%	6.2%	6.0%	-3.3%	4.6%	10.2%	11.3%	13.6%	4.5%	7.3%	4.8%	5.0%	1.8%	0.5%
Other income	9	4	10	1	1	1	3	0	1	1	2	11	1	6	21	1	3	10	2	6	2	2	6	2	12	1	10	9	5	3	24	1	5
Interest	4	9	9	11	14	8	15	11	8	7	12	10	9	7	10	19	18	12	10	10	20	14	16	23	26	34	16	16	19	18	23	14	21
Depreciation	10	7	8	7	8	8	9	9	10	13	12	13	13	13	16	14	14	16	18	19	19	21	20	20	21	14	18	17	19	17	21	19	20
Profit before tax	5	2	10	-2	9	14	13	32	17	28	29	33	1	41	20	15	26	32	8	16	-12	-10	-94	-23	-143	2	29	-5	0	-28	-7	-34	-35
Tax	10	6	8	-1	1	10	11	11	8	8	13	9	5	14	7	11	16	9	5	4	9	5	-12	11	-26	7	8	-0	6	0	-6	-0	-7
Net profit	-3	-6	1	-2	7	5	3	15	6	15	14	22	-6	29	15	6	13	24	9	16	-19	-12	-77	-34	-100	-4	-1	-10	-14	-36	88	-32	-28
EPS ₹	-0.66	-0.49	0.11	-0.17	0.57	0.43	0.22	1.27	0.49	1.26	1.16	1.75	-0.43	2.25	1.16	0.37	0.83	1.53	0.59	0.96	-1.17	-0.71	-4.64	-2.03	-5.98	-0.24	-0.04	-0.53	-0.76	-1.91	4.59	-1.65	-1.45
Revenue YoY	—	—	—	—	10.4%	13.5%	—	—	15.5%	8.8%	11.5%	8.2%	21.2%	27.8%	19.2%	16.0%	55.3%	1.8%	9.6%	9.3%	-16.0%	-0.5%	-5.9%	-5.7%	4.2%	12.3%	8.9%	7.0%	8.7%	5.5%	-2.9%	22.7%	6.9%
Profit YoY	—	—	—	—	429.8%	—	—	—	-15.1%	198.8%	434.5%	45.3%	-193.9%	86.3%	6.0%	-73.7%	—	-16.3%	-39.5%	164.0%	-248.8%	-149.0%	-942.1%	-318.3%	—	—	—	—	—	—	—	—	—

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Camlin Fine Sciences Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	101	125	165	252	314	374	431	412	325
Operating profit	14	16	20	36	46	59	61	68	25
Operating margin	14.2%	12.7%	12.3%	14.1%	14.6%	15.7%	14.1%	16.4%	7.6%
Other income	0	1	2	4	3	2	2	4	14
Interest	6	6	8	16	18	22	21	22	26
Depreciation	4	4	5	6	9	9	10	10	12
Profit before tax	5	7	8	16	23	29	32	35	1
Tax	2	2	2	6	8	10	6	9	1
Net profit	3	4	7	10	15	19	26	26	0

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	20	21	23	20	26	22	32	26	30	33	37	31	39	42	52	52	70	56	74	72	83	77	81	78	95	91	111	88	99	109	135	99	103	102	108	102	71	69	83	70	85	118
Operating profit	3	4	4	4	4	3	4	5	5	3	3	3	6	5	6	8	10	9	9	12	13	9	12	13	14	16	15	14	14	16	17	16	16	17	19	18	9	1	-3	2	-3	-8
Operating margin	13.5%	18.8%	15.4%	18.2%	13.8%	12.8%	13.0%	17.6%	15.4%	10.4%	9.2%	10.8%	14.4%	11.8%	12.0%	15.2%	14.3%	15.6%	12.1%	16.6%	15.3%	11.7%	14.8%	17.0%	14.8%	17.9%	13.6%	16.2%	14.3%	14.7%	12.3%	15.9%	15.1%	16.5%	18.0%	17.5%	12.7%	0.8%	-3.4%	2.8%	-3.5%	-7.0%
Other income	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	2	0	0	0	0	0	2	1	0	0	1	0	1	0	0	1	2	1	1	1	1	10	2	1	6	3
Interest	1	2	1	1	1	1	2	2	2	1	1	2	2	2	3	3	4	4	5	4	4	4	5	5	5	6	6	5	5	5	6	6	5	6	6	6	5	7	7	6	6	7
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2	2	2	2	2	2	2	3	2	3	3	3	2	2	3	3	3	3	3	3	3	2	2	2
Profit before tax	1	1	1	2	1	1	2	2	2	1	1	1	3	2	2	4	7	3	3	6	6	3	7	7	8	8	7	8	7	8	9	8	5	9	12	10	2	0	-11	-6	-6	-14
Tax	0	0	0	0	0	0	1	1	1	1	-0	0	1	1	-0	1	2	2	2	1	2	1	3	2	2	3	4	2	2	2	0	3	1	3	2	4	1	0	-3	-2	-2	-6
Net profit	0	1	1	1	1	0	1	1	1	0	1	1	2	1	3	3	5	2	1	4	4	2	4	5	6	5	3	5	5	7	8	5	4	7	10	6	1	0	-8	-4	-4	-8
EPS ₹	0.89	1.67	1.59	2.01	1.74	0.68	1.41	2.25	2.42	0.77	1.94	1.35	—	1.30	4.71	2.73	5.15	1.64	0.27	0.92	0.91	0.46	0.87	1.06	1.24	1.02	0.72	1.15	0.54	0.72	0.88	0.57	0.40	0.68	0.10	0.67	0.11	0.01	-0.75	-0.34	-0.35	-1.16
Revenue YoY	—	—	—	—	26.3%	8.1%	41.3%	25.7%	14.8%	49.4%	14.0%	20.4%	31.8%	27.4%	43.5%	67.5%	78.7%	32.2%	41.6%	39.4%	19.3%	36.9%	9.2%	7.9%	13.6%	18.7%	36.3%	13.4%	4.3%	19.0%	22.1%	12.6%	4.2%	-6.5%	-19.8%	2.7%	-30.8%	-32.2%	-23.8%	-31.1%	19.6%	71.4%
Profit YoY	—	—	—	—	134.9%	-59.8%	1.2%	12.0%	39.6%	15.4%	37.8%	-39.7%	36.9%	168.9%	141.6%	221.5%	148.7%	26.4%	-53.1%	68.5%	-11.3%	41.2%	217.2%	15.9%	36.4%	122.2%	-16.3%	10.3%	-12.4%	42.5%	147.6%	0.4%	-24.8%	-4.4%	17.5%	17.9%	-72.1%	-98.5%	-176.9%	-154.9%	-443.0%	-8280.0%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 27 periods

	DEC '18	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	8.4%	7.7%	6.4%	7.5%	3.1%	-0.7%	-10.7%	-16.5%	-32.3%	-31.2%	-15.4%	-12.8%	-3.3%	-6.9%	2.7%	0.6%	-0.8%
ROCE	—	—	—	—	—	—	—	—	—	—	10.4%	10.1%	8.7%	8.2%	5.9%	3.5%	-2.6%	-4.3%	-13.3%	-11.1%	-2.3%	-1.6%	7.2%	4.3%	2.2%	0.4%	-1.7%
Net margin	-1.1%	2.8%	2.6%	3.4%	4.3%	4.8%	3.7%	4.4%	4.3%	3.0%	3.8%	3.5%	3.1%	3.6%	1.8%	-0.4%	-5.8%	-9.0%	-13.9%	-13.0%	-8.2%	-6.7%	-1.7%	-3.4%	1.6%	0.3%	-0.4%
EBITDA margin	6.7%	13.2%	13.2%	14.4%	15.3%	14.6%	13.1%	12.9%	10.5%	10.2%	11.1%	10.7%	11.6%	10.9%	9.6%	8.0%	4.6%	3.4%	4.4%	5.9%	10.0%	9.9%	9.2%	7.5%	5.4%	4.6%	2.9%
Debt / equity	—	—	—	—	—	—	—	—	—	—	0.98	0.98	0.95	0.95	0.71	0.71	0.76	0.76	1.07	1.07	0.72	0.72	0.72	0.72	0.64	0.64	0.65
Interest coverage	1.45	2.40	2.82	3.19	3.80	3.86	3.36	3.70	3.63	2.72	2.88	2.57	2.37	2.64	1.86	1.05	-0.65	-0.89	-2.36	-1.58	-0.36	-0.27	1.30	0.95	0.49	0.09	-0.36
Asset turnover	—	—	—	—	—	—	—	—	—	—	0.85	0.85	0.82	0.83	0.81	0.81	0.83	0.81	0.85	0.88	0.83	0.85	0.86	0.87	0.76	0.80	0.83

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	16	16	17	17	17	19	19	19	19
Other equity / reserves	735	804	926	848	673	883	871	1,022	953
Total equity	750	819	943	865	690	902	890	1,041	972
Borrowings	739	780	666	658	739	646	642	668	629
Current liabilities	745	793	681	732	851	846	856	974	1,017
Non-current liabilities	421	443	390	362	369	303	320	349	319
Total assets	1,927	2,060	2,014	1,952	1,885	2,024	2,037	2,324	2,268
Property, plant & equipment	505	794	780	757	583	593	630	625	633
Capital work-in-progress	330	41	50	46	22	10	15	33	24
Investments	7	8	8	8	23	61	69	30	31
Inventories	433	568	591	513	501	527	531	504	581
Receivables	340	305	241	285	309	328	326	373	337
Cash & equivalents	86	94	92	80	80	104	87	109	50

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	145	51	139	27	82
Cash from investing	-249	-125	-66	-75	-53
Cash from financing	136	60	-86	72	-25
Capex	214	144	61	42	58
Free cash flow	-68	-93	78	-16	24
Dividends paid	0	0	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹633 cr28%

CWIP

₹24 cr1%

Investments

₹31 cr1%

Inventories

₹581 cr26%

Receivables

₹337 cr15%

Cash & equivalents

₹50 cr2%

Other assets

₹613 cr27%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Camlin Fine Sciences Limited	1,460	76.03	—	1.50	-0.8%

StoxGud checklist: Bearish setup · 2/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-19.6%

6 months-44.2%

1 year-62.2%

3Y CAGR-18.3%

5Y CAGR-14.4%

10Y CAGR-4.0%

50-day avg₹93.53

200-day avg₹120.33

RSI (14)30

FAQs

What is the share price of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited (CAMLINFINE) closed at ₹76.03 on NSE on 06 Nov 2026.

What is the market cap of Camlin Fine Sciences Limited?

₹1,460 crore at the latest close.

How fast is Camlin Fine Sciences Limited growing?

Camlin Fine Sciences Limited: revenue has compounded at 0.8% a year over three years; net profit at -19.1% a year. Latest-quarter revenue is up 6.9% year on year.

How profitable is Camlin Fine Sciences Limited?

On a trailing-twelve-month basis return on equity is -0.8%, return on capital employed -1.7%, operating margin 2.9%, net margin -0.4%.

How much debt does Camlin Fine Sciences Limited have?

Camlin Fine Sciences Limited is moderately geared: debt to equity is 0.65 with borrowings of ₹629 cr against cash of ₹50 cr (balance sheet of 2026-09-30). Operating profit covers interest -0.4 times.

Financials parsed from Camlin Fine Sciences Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.